Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
life sciences
national blog main
4
×
startups
4
×
boston blog main
boston top stories
deals
national top stories
san francisco blog main
boston
ipo
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
vc
480 biomedical
acetylon pharmaceuticals
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
ambys medicines
arsenal medical
athena countouriotis
azacitidine
beta-thalassemia
bob langer
brett zbar
bristol-myers squibb
cell therapy
chronic rhinosinusitis
clinical trials
constellation pharmaceuticals
cormorant asset management
covid-19
dacogen
daiichi sankyo
decitabine
dna
What
biotech
4
×
new
4
×
therapeutics
developing
medicines
million
raised
startup
aiming
aims
ambys
approach
athena
based
big
called
cancer
ceo
chief
company
control
countouriotis
deadly
deal
debut
debuted
debuts
diseases
drug
drugs
epigenetic
epigenetics
field
financing
flagship’s
formed
future
gets
ipo
late
Language
unset
Current search:
new
×
startups
×
photo
×
biotech
×
" national blog main "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?